VistaGen Therapeutics Inc
NASDAQ:VTGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
VistaGen Therapeutics Inc
NASDAQ:VTGN
|
US |
|
Goliath Resources Ltd
F:B4IF
|
CA |
|
S
|
SPAR Group Ltd
JSE:SPP
|
ZA |
|
T
|
Technology Minerals PLC
LSE:TM1
|
UK |
|
P
|
Power Root Bhd
KLSE:PWROOT
|
MY |
|
Banco Comercial Portugues SA
ELI:BCP
|
PT |
|
G
|
Graham Holdings Co
XBER:WPOB
|
US |
|
V
|
Veeco Instruments Inc
XBER:VEO
|
US |
|
Alithya Group Inc
F:0QZ
|
CA |
|
Nissin Foods Holdings Co Ltd
OTC:NFPDF
|
JP |
|
M
|
Mohawk Industries Inc
LSE:0K2F
|
US |
|
Corteva Inc
NYSE:CTVA
|
US |
|
Sulzer AG
F:SUL1
|
CH |
|
Pennant International Group PLC
LSE:PEN
|
UK |
|
Magnetic Resources NL
ASX:MAUCA
|
AU |
|
Protagonist Therapeutics Inc
NASDAQ:PTGX
|
US |
|
S
|
SFC Energy AG
XBER:F3C
|
DE |
|
MacroGenics Inc
NASDAQ:MGNX
|
US |
|
Sivers Semiconductors AB
OTC:SIVEF
|
SE |
|
Addtech AB
OTC:ADDHY
|
SE |
|
Titan Biotech Ltd
BSE:524717
|
IN |
|
S
|
Synergy Grid and Development Phils Inc
XPHS:SGP
|
PH |
|
Genmab A/S
F:GE91
|
DK |
|
A
|
Africa Oil Corp
XMUN:AFZ
|
CA |
Bankruptcy Probability
VistaGen Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
VistaGen Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
V
|
VistaGen Therapeutics Inc
NASDAQ:VTGN
|
9.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
453.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
70.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
VistaGen Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, VistaGen Therapeutics Inc has total debt of 96k USD. This includes both short-term (96k USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
